Oncology Institute Inc (NASDAQ: TOI) started the day on Wednesday, with a price increase of 4.80% at $3.71, before settling in for the price of $3.54 at the close. Taking a more long-term approach, TOI posted a 52-week range of $0.13-$3.78.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -488.57% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -488.57%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 32.86%. This publicly-traded company’s shares outstanding now amounts to $88.93 million, simultaneously with a float of $45.65 million. The organization now has a market capitalization sitting at $341.00 million. At the time of writing, stock’s 50-day Moving Average stood at $2.80, while the 200-day Moving Average is $1.33.
Oncology Institute Inc (TOI) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Care Facilities Industry. Oncology Institute Inc’s current insider ownership accounts for 50.33%, in contrast to 14.64% institutional ownership. According to the most recent insider trade that took place on Jun 05 ’25, this organization’s Director sold 673,676 shares at the rate of 3.05, making the entire transaction reach 2,054,712 in total value, affecting insider ownership by 13,950,557. Preceding that transaction, on Jun 05 ’25, Company’s Director sold 76,324 for 3.05, making the whole transaction’s value amount to 232,788. This particular insider is now the holder of 1,272,724 in total.
Oncology Institute Inc (TOI) Earnings and Revenue Records
Oncology Institute Inc’s EPS increase for this current 12-month fiscal period is 32.86% and is forecasted to reach -0.18 in the upcoming year.
Oncology Institute Inc (NASDAQ: TOI) Trading Performance Indicators
Let’s observe the current performance indicators for Oncology Institute Inc (TOI). It’s Quick Ratio in the last reported quarter now stands at 1.59. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.85.
In the same vein, TOI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.70, a figure that is expected to reach -0.12 in the next quarter, and analysts are predicting that it will be -0.18 at the market close of one year from today.
Technical Analysis of Oncology Institute Inc (TOI)
If we take a close look at the recent performances of Oncology Institute Inc (NASDAQ: TOI), its last 5-days Average volume was 2.51 million that shows progress from its year to date volume of 1.4 million. During the previous 9 days, stock’s Stochastic %D was recorded 83.47% While, its Average True Range was 71.84%.
Raw Stochastic average of Oncology Institute Inc (TOI) in the period of the previous 100 days is set at 97.80%, which indicates a major rise in contrast to 95.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.30 that was higher than 0.29 volatility it exhibited in the past 100-days period.
